Location: Home
  • search
  • go
  • Relate News
  • 5/17/2022Upcoming Event: 6th International Conference on Emerging Infectious Di...
  • 5/17/2022SMEI: Chinese Public Medical Institution Drug Sales Surged 7.2% in 202...
  • 5/17/2022CDE Issues the Guidelines for Evaluation of Immune-Related Adverse Eve...
  • 5/17/2022NHSA Completes Building of Unified National BMI Information Platform
  • 5/17/2022433 Listed Chinese Pharma Companies Report Their Annual Performance in...
  • 5/16/2022Visus and Zhaoke Enter Exclusive Licensing Deal for Brimochol PF and C...
  • 5/16/2022Kelun Out-licenses Anticancer Drug Candidate to MSD in $1.4B Deal
  • 5/16/2022Bayer's Q1/2022 Business Undercut by Xarelto Generics in China
  • 5/16/2022Kintor Pharma Included in MSCI China Index
  • 5/16/2022Pfizer Leads April Approvals in China with Two JAK Inhibitors (PharmaD...
  • 5/16/2022Judgement on the First Drug Patent Linkage Lawsuit in China Is Issued
  • 5/13/2022Green Valley Aborts Trial of Its Alzheimer's Drug amid Fundraisng and ...
  • 5/13/2022Drug R&D and Product Registration News Digest May 2022 (2)
  • 5/13/2022Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2021
  • 5/13/2022SMEI: Top 20 Pharma Cos by Hospital Drug Sales in 2021
  • 5/12/2022Henlius and Eurofarma Entered into a License Deal for Three Henlius P...
  • 5/12/2022Merck KGaA Warns of Volatile 2022 Thanks to War in Ukraine and Fresh C...
  • 5/12/2022China Resources in Talks to Take Sihuan Pharma Private At $3B Valuatio...
  • 5/12/2022Chinese Securities Regulators Lay Out Audit Pathway for U.S. Listings ...
  • 5/12/2022Ready for FDA, Can Hengrui's China-made PD-1 Liver Cancer Immunotherap...
  • 5/11/2022BeiGene, Hutchmed, Zai Lab Tagged for Potential US Delisting Under SEC...
  • 5/11/2022China to Help More Biotech Firms Get Listed Domestically to Boost Sect...
  • 5/11/2022China Rolls Out Five Year Plan to Develop $3.28 Trillion Bioeconomy ...
  • 5/11/2022NMPA Issues the 14th FYP for Drug Regulatory Network Safety and IT Bui...
  • 5/11/2022Review of Top 10 Listed Chinese Biotech Firms by R&D Spending in 2021
  • 5/10/2022NMPA Issues Two Guidelines for TCM Registration and Evaluation
  • 5/10/2022NMPA Solicits Comments on the Draft Implementation Rules for Drug Admi...
  • 5/10/2022Coherus Biosciences Terminates Deal With Innovent for Avastin Biosimil...
  • 5/9/2022SMEI: Review of Chinese Terminal Drug Markets in 2011 – 2021
  • 5/9/2022China's Pharma Companies Are Spending Big on R&D, But Global Success R...
  • Page:155/789 Total number of articles:23668: [First][<<] [153] [154] [155] [156] [157] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group